Posted in Market

UroGen outlines $5B market opportunity as UGN-102 FDA review nears and commercial launch preparations accelerate

Reporter



UroGen outlines $5B market opportunity as UGN-102 FDA review nears and commercial launch preparations accelerate



Source link

You May Also Like

4 ways Apple’s transformative ‘product renaissance’ is taking shape

Tory Lanez Stabbed In Prison, Rushed to Hospital: Report

Leave a Reply

Your email address will not be published. Required fields are marked *